Effect of peginterferon beta-1a on MRI measures and achieving no evidence of disease activity: results from a randomized controlled trial in relapsing-remitting multiple sclerosis
Crossref DOI link: https://doi.org/10.1186/s12883-014-0240-x
Published Online: 2014-12-31
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Arnold, Douglas L
Calabresi, Peter A
Kieseier, Bernd C
Sheikh, Sarah I
Deykin, Aaron
Zhu, Ying
Liu, Shifang
You, Xiaojun
Sperling, Bjoern
Hung, Serena
License valid from 2014-12-01
Article History
Received: 3 July 2014
Accepted: 5 December 2014
First Online: 31 December 2014